drugset / Trial / NCT02696512
A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a study to evaluate the safety and efficacy of the IBRF ACP/MCP intervention protocol in patients with severe disorders of consciousness (SDOC).
Timeline
- Start
- 2016-03
- Primary completion
- 2017-03
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetylcarnitine | Small molecule | — | — |
| Subject | Amantadine | Unknown | — | — |
| Subject | Bromocriptine | Small molecule | — | — |
| Subject | Carbidopa | Unknown | — | — |
| Subject | Donepezil | Small molecule | — | — |
| Subject | Flumazenil | Small molecule | — | — |
| Subject | Lactobacillus acidophilus | Other / unclassified | — | — |
| Subject | Lamotrigine | Small molecule | — | — |
| Subject | Levodopa | Unknown | — | — |
| Subject | Methylfolate | Unknown | — | — |
| Subject | Methylphenidate | Small molecule | — | — |
| Subject | Minocycline | Small molecule | — | — |
| Subject | Modafinil | Small molecule | — | — |
| Subject | Naltrexone | Small molecule | — | — |
| Subject | Rasagiline | Small molecule | — | — |
| Subject | alpha-lipoic acid | Small molecule | — | — |
| Subject | methylcobalamin | Small molecule | — | — |